Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment
about
Compulsivity in anorexia nervosa: a transdiagnostic conceptNeuroinflammation and psychiatric illnessThe neurobiological link between OCD and ADHDA critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorderExpanding frontiers in weight-control research explored by young investigatorsNeuroimaging Studies in Obsessive Compulsive Disorder: A Narrative ReviewStriatopallidal dysfunction underlies repetitive behavior in Shank3-deficient model of autism.OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor bindingUsing mice to model Obsessive Compulsive Disorder: From genes to circuits.Repeated cortico-striatal stimulation generates persistent OCD-like behavior.In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of conceptCan Neuroimaging Provide Reliable Biomarkers for Obsessive-Compulsive Disorder? A Narrative Review.Brain Gamma-Aminobutyric Acid (GABA) Concentration of the Prefrontal Lobe in Unmedicated Patients with Obsessive-Compulsive Disorder: A Research of Magnetic Resonance Spectroscopy.Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopyGenome-wide association study of obsessive-compulsive disorder.N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic reviewGenome-wide association study in obsessive-compulsive disorder: results from the OCGASRandomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept.Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial.Cefdinir for recent-onset pediatric neuropsychiatric disorders: a pilot randomized trial.Assessment of glutamate in striatal subregions in obsessive-compulsive disorder with proton magnetic resonance spectroscopy.DISSECTING OCD CIRCUITS: FROM ANIMAL MODELS TO TARGETED TREATMENTS.Glutamate modulators in the treatment of obsessive-compulsive disorder.Glutamatergic agents for OCD and related disordersTopiramate augmentation in a patient with obsessive-compulsive disorder.Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial.COMPULS: design of a multicenter phenotypic, cognitive, genetic, and magnetic resonance imaging study in children with compulsive syndromes.Does compulsive behavior in Anorexia Nervosa resemble an addiction? A qualitative investigationLearning From Animal Models of Obsessive-Compulsive DisorderBehavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications.An Examination of Rostral Anterior Cingulate Cortex Function and Neurochemistry in Obsessive-Compulsive Disorder.Effects of ketamine in treatment-refractory obsessive-compulsive disorder.Isoforms of the neuronal glutamate transporter gene, SLC1A1/EAAC1, negatively modulate glutamate uptake: relevance to obsessive-compulsive disorderAn integrated molecular landscape implicates the regulation of dendritic spine formation through insulin-related signalling in obsessive-compulsive disorder.Treatment Efficacy of Combined Sertraline and Guanfacine in Comorbid Obsessive-Compulsive Disorder and Attention Deficit/Hyperactivity Disorder: Two Case StudiesLamotrigine Augmentation Versus Placebo in Serotonin Reuptake Inhibitors-Resistant Obsessive-Compulsive Disorder: A Randomized Controlled Trial.Serum Cytokine Profiles of Children with Obsessive-Compulsive Disorder Shows the Evidence of Autoimmunity.Management of obsessive-compulsive disorder comorbid with bipolar disorder.Fronto-striatal glutamate in children with Tourette's disorder and attention-deficit/hyperactivity disorder.Putting the Pieces Together in Gilles de la Tourette Syndrome: Exploring the Link Between Clinical Observations and the Biological Basis of Dysfunction.
P2860
Q21129131-C5EF98B3-3556-4590-A218-1A569DC30A60Q21245244-765FF54B-B153-48A1-A9B2-A2983FBF2BD6Q27002629-AA25CA46-E4B0-493C-8320-C7315822A769Q27025872-E1221682-5A7F-49B8-A3DA-4BF467B7C5CCQ28077983-77E28C08-0448-4A59-944C-9503C609FD0EQ28080328-B5EFABAF-D7A5-4BCE-8CC1-400254A219D3Q30008746-F538691F-EF45-4D6D-9AF1-598342655A66Q30356289-9E49F125-C5C7-44D8-9A95-61FB355B0DF8Q30357295-CFEC54B8-B01C-4063-9385-5E9AF8D789F4Q30574071-07CC03AE-61CD-4706-864C-62BEEFE24BD9Q30976220-A2661DF7-24FD-46AA-8943-8051B8FE9E70Q31122964-53DC6E30-AABB-4A47-9FE3-D363815C4D01Q33695800-5EE022EA-4ADB-4226-B332-ED7DFE9B527DQ34360615-F054862F-2628-4AE1-9D64-2D488E309804Q34445418-171B6F13-00EB-4108-B55A-28A66A363089Q34473631-3612D0C1-3F3F-422B-80C5-3BFF3F8D4592Q34506200-2BA36D6A-1DC2-44D2-8C50-275E2E36B499Q34653386-401D9588-1D2D-4D33-85BF-D9F98A9CD5D4Q34678136-159D5805-EC82-484B-AAB0-3EDD6C4B802FQ35121068-549BE647-C05E-44CC-BE2F-0F6B4A85DE73Q35498859-93F7A4D6-4D70-47CD-9E86-6346BD6E0E4FQ35889362-18EC1C2B-C2C9-4524-95FC-EFC6869053BCQ35897264-9E514A8C-E401-4CB2-A4D9-80A954B6F8ABQ35967025-D7A4A4E1-2286-4F52-8D10-518FD05615D3Q35976177-EC63D77F-7742-41C1-BE1D-DBB63D0DB35EQ36029739-C999D7D8-41A3-40B1-AA9D-A5FC13A04DC8Q36174652-5FF0BC9E-E593-4C7B-9A06-7BF04F4A7C6DQ36178071-85A88E33-CE56-4A3E-94F3-CA5445EAC425Q36249163-AFA52459-F9AC-4709-9066-4BB151400E64Q36582018-92266671-2BD7-4C11-B790-40F397EBEB25Q36821758-B740C734-52F5-4192-9C74-B50671F4E390Q36887096-07DDD821-B10B-46A6-B99A-79B2F92C7303Q36894271-6DF9A8DE-514F-426B-80F4-49B3110A3C4AQ37026324-D3E0C911-0220-4D24-BB34-7FE07938D414Q37059161-9F33DF24-C8F1-4F50-BBF6-B82C844E2F92Q37099618-57562B48-0353-4045-9302-87C3B1B504F9Q37220482-946A9F45-9AE3-4A5E-8AB4-6317D0E15083Q37400532-89AFF5D9-4EB8-406F-8269-96AA8E9D47F3Q37442996-FAE9CC46-ACBC-4D42-907D-76F5846802FDQ37568876-6824857B-8982-4957-913C-4E376633C9F1
P2860
Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Glutamate abnormalities in obs ...... pathophysiology, and treatment
@ast
Glutamate abnormalities in obs ...... pathophysiology, and treatment
@en
Glutamate abnormalities in obs ...... pathophysiology, and treatment
@nl
type
label
Glutamate abnormalities in obs ...... pathophysiology, and treatment
@ast
Glutamate abnormalities in obs ...... pathophysiology, and treatment
@en
Glutamate abnormalities in obs ...... pathophysiology, and treatment
@nl
prefLabel
Glutamate abnormalities in obs ...... pathophysiology, and treatment
@ast
Glutamate abnormalities in obs ...... pathophysiology, and treatment
@en
Glutamate abnormalities in obs ...... pathophysiology, and treatment
@nl
P2860
P3181
P1476
Glutamate abnormalities in obs ...... pathophysiology, and treatment
@en
P2093
Kyle Williams
Michael H Bloch
P2860
P304
P3181
P356
10.1016/J.PHARMTHERA.2011.09.006
P407
P577
2011-12-01T00:00:00Z